Back to expert views

90-day Window Unmet Need Video

Join Dr Kenneth Mahaffey, MD as he explores the impact of recurrent MI and explains why there is currently an unmet need for therapies that can reduce the risk of recurrent cardiovascular events in the high-risk 90-day period after an AMI.

Dr Kenneth Mahaffey



Continue to

Prof Stephen Nicholls

Evolution of the HDL hypothesis: Current insights

Listen to Prof Stephen Nicholls provide his expert insights on why the HDL hypothesis is shifting from a focus on HDL levels to HDL function. He describes ApoA-I, the key functional component of HDL, and the role it plays in the mechanism of cholesterol efflux, the pivotal first step in reverse cholesterol transport

Listen Now
Susan Gabriel, Ph.D.

Recurrent CV events post-AMI in patients with MVD: A retrospective study in the UK

Listen to Dr. Susan Gabriel share her insights on risk factors for recurrent cardiovascular events following myocardial infarction in a large real-world data analysis of 78,000 patients with multivessel disease.

Listen Now


ACC, American College of Cardiology; ACS, acute coronary syndrome; AHA, American Heart Association; AMI, acute myocardial infarction; ApoA-I, apolipoprotein A-I; ASCVD, atherosclerotic cardiovascular disease; CV, cardiovascular; ESC, European Society of Cardiology; HDL, high-density lipoprotein; LDL, low-density lipoprotein 


USA-GEN-0051 | August 2023